[1]
P. Gieszinger, G. Katona, P. Szabó-Révész, and R. Ambrus, “Stability study of nasal powder formulation containing nanosized lamotrigine”, Acta Pharm Hung, vol. 90, no. 1, pp. 27-31, Jun. 2020.